ACTICOAT◊ FLEX Antimicrobial Barrier Dressings
Combines nanocrystalline silver (NCS) technology with a flexible low-adherent layer to conform to body contours, delivering a sustained antimicrobial action for up to 7 days*1-5
Combines nanocrystalline silver (NCS) technology with a flexible low-adherent layer to conform to body contours, delivering a sustained antimicrobial action for up to 7 days*1-5
*Depending on dressing selection. ACTICOAT FLEX 3 offers up to 3 days’ use. ACTICOAT FLEX 7 offers up to 7 days’ use.
**As demonstrated in vitro.
1. Smith+Nephew 2011. Internal report. SR/CE/036/ACB.
2. Smith+Nephew 2008. Internal report. DOF 0810016.
3. Smith+Nephew 2008. Internal report. DOF 0810017.
4. Smith+Nephew 2008. Internal report. DOF 0810012.
5. Smith+Nephew 2008. Internal report. DOF 0810013.
6. Smith+Nephew. A 17-Day wound healing study in full-thickness wounds in minipigs. Internal Statement.
7. Wright JB, et al. Am J Infect Control. 1998;26(6):572 - 577.
8. Wright JB, et al. Am J Infect Control. 1999;27(4):344 - 350.
9. Smith+Nephew 2017. Internal report. DS/16/363/R2.
10. Westaim Biomedical 2001. Internal report - 971030.
11. Smith+Nephew 2008. Internal report. DS/08/123/R1.
12. Cuttle L, et al. Burns. 2007;33(6):701 - 707.
13. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.001.v2.
14. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.002.v2.
15. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.003.v2.
16. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.004.v2.
17. Gago M, et al. Wounds. 2008;20(10):273 - 278.
18. Demling RH, et al. Burns. 2002;28(3):264 - 266
19. Smith+Nephew 2008. Internal report. DOF 0810018.
20. Smith+Nephew 2008. Internal report. DOF 0810014.
21. Yin HQ, et al. J Burn Care Rehabil. 1999;20(3):195 - 200.
22. Wright JB, et al. Wounds. 1998;10(6):179 - 188.
23. Smith+Nephew 2008. Internal report. DS/08/062/R1.
24. Westaim Biomedical 2000. Internal report - 001213.
25. Westaim Biomedical 2001. Internal report - 010322.
26. Glik J, et al. Int Wound J. 2018;15(3):344 - 349.